Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Greenlab New Zealand Signs White-Label Agreement To Supply Australian Medical Cannabis Market

Greenlab (Green Relief NZ Ltd trading as Greenlab) based at Lincoln University is positioning New Zealand at the forefront of research-driven pharmaceutical-quality cannabis cultivation and derivative products, is pleased to announce that its subsidiary, Greenlab Australia Pty Ltd, has entered into an agreement to supply pharmaceutical-grade, cannabinoid pharmaceuticals to Cannvalate Pty Ltd, one of Australia’s largest distributors.

Under the two-year agreement, Greenlab will supply a range of certified cannabis products that meet the high-quality standards set by the Australian Therapeutic Goods Administration (TGA) and meeting internationally recognized GMP requirements. Greenlab and Cannvalate will non-exclusively distribute the products to medical patients approved through the TGA’s Special Access Scheme, on a consignment basis.

Approximately $2.4 million of committed revenue stream (depending on mix of derivative products selected) expected to be received by Greenlab over the 24-month term with an option for an extension for an additional year on the same terms and conditions.

“We are excited to be working with Cannvalate in Australian market to bring new formulations and products to the New Zealand market in near future” said Kevin Edgar, CEO of Greenlab, New Zealand. Kevin further said this agreement underlines Greenlab commitment to start creating and manufacturing its own unique formulations for New Zealand and global legal markets.

“We look forward to collaborating with Greenlab and assisting with the distribution of their high quality and market orientated products in Australia and New Zealand.” said Darryl Davies, COO of Cannvalate.

Greenlab white label products are currently being manufactured by The Valens (TSX: VLNS) and Mile High Labs UK said Kevin Edgar. This is an important development in Greenlab’s initial product strategy and will be an opportunity for Greenlab with Cannvalate to supply prescribers with quality medicinal cannabis products. As New Zealand is set to start seeing increased demand from patients for medicinal cannabis, Greenlab will be ready to provide patients with a reliable supply of innovative pharma-quality products they can trust, and this is the first step in that process.

About Green Relief NZ Ltd trading as Greenlab, New Zealand

Greenlab, founded in 2019, became one of the first New Zealand’s South Island company to secure a R&D licence. Greenlab is based at Lincoln University to carry out industry focused R&D in fully controlled environments which will be scaled up in commercial cultivation facility to manufacture unique products.

About Cannvalate, Australia

Cannvalate is a cannabis business solution provider helping Licensed Producers fast track their growth into the Australasian market. Their three key services include (i) Australian Cannabis Market Access; (ii) Medicinal Cannabis Research; and (iii) Expert Clinical Consulting.

© Scoop Media

Business Headlines | Sci-Tech Headlines


Paymark: Lockdown Equals Slowdown For Some

The three days of lockdown for Auckland earlier this month made a clear impression on our retail spending figures. While only Auckland moved into Level 3 lockdown, the impact was felt across the country, albeit at different levels. Looking at the ... More>>

Infrastructure Commission: Te Waihanga Releases Report On Water Infrastructure

The New Zealand Infrastructure Commission, Te Waihanga’s latest discussion document highlights the importance of current reforms in the water sector. Its State of Play discussion document about water infrastructure is one of a series looking at the ... More>>

Sci-Tech: Perseverance Rover Lands On Mars – Expert Reaction

NASA has landed a car-sized rover on the red planet to search for signs of past life. The vehicle has more instruments than the four rovers preceding it, and it’s also carrying gear that could help pave the way for human exploration of Mars. The ... More>>


ASB: Quarterly Economic Forecast Predicts OCR Hike As Early As August 2022

Predictions of interest rate rises have been brought forward 12 months in ASB’s latest Quarterly Economic Forecast. Chief Economist Nick Tuffley now expects the RBNZ to begin raising the OCR from its current level of 0.25% as early as August ... More>>

ACT: Matariki Almost A Half Billion Dollar Tax On Business

“Official advice to the Government says an extra public holiday at Matariki could cost almost $450 million,” ACT Leader David Seymour can reveal. “This is a perfect example of the Prime Minister doing what’s popular versus what’s responsible. ... More>>

Genesis: Assessing 6,000 GWh Of Renewable Generation Options For Development By 2025

Genesis is assessing 6,000 GWh of renewable generation options for development after starting a closed RFP process with 11 partners. Those invited to participate offer a range of technologies as Genesis continues to execute its Future-gen strategy to ... More>>

OECD: Unemployment Rate Stable At 6.9% In December 2020, 1.7 Percentage Points Higher Than In February 2020

The OECD area unemployment rate was stable at 6.9% in December 2020, remaining 1.7 percentage points above the level observed in February 2020, before the COVID-19 pandemic hit the labour market. [1] In December, the unemployment rate was also stable ... More>>

Stats NZ: Unemployment Drops To 4.9 Percent As Employment Picks Up

The seasonally adjusted unemployment rate dropped to 4.9 percent in the December 2020 quarter, from 5.3 percent in the September 2020 quarter, Stats NZ said today. Last quarter’s unemployment rate of 5.3 percent followed the largest increase observed ... More>>